Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype

By Caggiari Laura   Miolo Gianmaria   Buonadonna Angela   Basile Debora   Santeufemia Davide A.   Cossu Antonio   Palmieri Giuseppe   De Zorzi Mariangela   Fornasarig Mara   Alessandrini Lara   Canzonieri Vincenzo   Lo Re Giovanni   Puglisi Fabio   Steffan Agostino   Cannizzaro Renato   De Re Valli  

International Journal of Molecular Sciences, Vol. 19, Iss. 1, 2017-12 ,pp. : 47-47

MDPI

Access to resources Recommend Favorite

Intrapleural Administration of Cisplatin and Etoposide to Treat Malignant Pleural Effusions in Patients with Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 45, Iss. 3, 1999-04 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

By Lammers Philip   Criscitiello Carmen   Curigliano Giuseppe   Jacobs Ira  

Pharmaceuticals, Vol. 7, Iss. 9, 2014-09 ,pp. : 943-953

MDPI

Access to resources Recommend Favorite

The Safety of Concentrated Trastuzumab in 100 ml of Saline Solution for Administration to Patients with HER2-Positive Breast Cancer: A Phase 1 Study

By  

Chemotherapy, Vol. 60, Iss. 1, 2014-10 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Pre-Clinical Assessment of ¹⁷⁷Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease

By Ray Geoffrey L.   Baidoo Kwamena E.   Keller Lanea M. M.   Albert Paul S.   Brechbiel Martin W.   Milenic Diane E.  

Pharmaceuticals, Vol. 5, Iss. 1, 2011-12 ,pp. : 1-15

MDPI

Access to resources Recommend Favorite